Generix Group Stock

Generix Group Equity

Delisted

The The Equity of Generix Group (GENX.PA) as of Jul 26, 2026 is 46.16 M EUR. In the previous year, The Equity was 44.40 M EUR — a change of 3.96% (higher).

Equity

46.16 MEUR

YoY

3.96%

Last updated:

In 2026, Generix Group's equity was 46.16 M EUR, a 3.96% increase from the 44.40 M EUR equity in the previous year.

Access this data via the Eulerpool API

Generix Group Stock analysis

What does Generix Group do? Generix Group SA is a leading provider of software solutions for supply chain management and e-commerce. The company was founded in 1990 in France and has its headquarters in Paris. It employs over 1,000 employees and operates in Europe, North America, and Asia. Its business model is based on the development and sale of software solutions for optimizing supply chains and business processes. They offer a range of products including warehouse management systems, transport management systems, supply chain planning, electronic data interchange, and e-commerce platforms. The company is segmented into three business areas: supply chain collaboration, supply chain execution, and e-commerce. They offer solutions for collaboration between suppliers, customers, and partners, as well as inventory management, transportation, and delivery management. They also have platforms for online sales and distribution that cater to B2B and B2C companies. Some of their key products include collaborative supply chain management, warehouse management, and transportation management. They also develop innovative technologies such as robotic warehouses and cloud platforms for e-commerce. They are pioneers in artificial intelligence and machine learning, working closely with universities and research institutions. Overall, Generix Group SA has a strong position in the supply chain management and e-commerce solutions market, offering a wide range of products tailored to various industries. With their focus on innovation and technology, they are well positioned for future success. Generix Group is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Generix Group's Equity

Generix Group's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Generix Group's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Generix Group's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Generix Group's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Generix Group’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Generix Group stock

The Equity of Generix Group is 46.16 M EUR in 2026.

Access this data via the Eulerpool API

Balance Sheet — Generix Group

All Key Metrics — Generix Group